1. Home
  2. Live Updates
  3. Small cell lung cancer

Live Breaking News & Updates on Small cell lung cancer

Stay informed with the latest breaking news from Small cell lung cancer on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Small cell lung cancer and stay connected to the pulse of your community

Is the FDA Pausing More Cancer Trials? It's Hard to Tell

Clinical trial holds delay therapies getting to market and may be on the rise in oncology. But there's a lot the public doesn't know about how often these holds happen and why.

United-states , Boston , Massachusetts , Washington , American , Matthewe-brown , Joshua-sharfstein , Derek-scholes , Nelson-mullins , Julier-gralow , Johns-hopkins-bloomberg-school-of-public-health , American-society-of-clinical-oncology

Is Osimertinib Better Alone or With Chemotherapy in NSCLC?

A new study reveals that baseline EGFR mutations may be key to making the decision in the frontline setting.

Boston , Massachusetts , United-states , Illinois , University-of-chicago , Chicago , Dana-farber-cancer-institute , San-diego , California , American , Marina-garassino , Clinical-research-annual-meeting

Exeliom Biosciences announces three phase II clinical trials in immuno-oncology with lead candidate

Exeliom Biosciences announces three phase II clinical trials in immuno-oncology with lead candidate
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

France , Rennes , Bretagne , Saint-antoine , Aquitaine , Paris , France-general- , French , Faecalibacterium-prausnitzii , Philippe-langella , Patrick-gervais , Exeliom-bioscience

Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting

VANCOUVER, British Columbia, April 08, 2024 -- Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the...

San-diego , California , United-states , Vancouver , British-columbia , Canada , Ireland , United-kingdom , American , British , Paul-moore , Shrinal-inamdar

Zymeworks Inc.: Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting

Zymeworks Inc.: Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

San-diego , California , United-states , Vancouver , British-columbia , Canada , United-kingdom , British , American , Dennis-riedl , Shrinal-inamdar , Bispecific-tces

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study

RAS-mutated mCRC– In RAS-mutated mCRC, novel preclinical finding demonstrates onvansertib inhibits the tumor’s ability to adapt to hypoxia resulti...

San-diego , California , United-states , American , James-levine , Kiki-patel , Mark-erlander , Nasdaq , American-association-for-cancer-research , Online-program , Gilmartin-group , Taft-communications

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

California , United-states , San-diego , American , James-levine , Kiki-patel , Mark-erlander , Taft-communications , Gilmartin-group , American-association-for-cancer-research , Nasdaq , Online-program

AstraZeneca : Imfinzi significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung cancer in ADRIATIC Phase III trial - Form 6-K -April 05, 2024 at 06:26 am EDT

a4121j

FORM 6-K


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549


Report of Foreign Issuer


Pursuant to Rule 13a-16 or...

China , United-kingdom , Washington , United-states , Amsterdam , Noord-holland , Netherlands , Cambridge , Cambridgeshire , Japan , American , America

IMFINZI® (durvalumab) significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung cancer in ADRIATIC Phase III trial

First and only immunotherapy to demonstrate survival benefit in this setting in a global Phase III trial

...

United-states , China , United-kingdom , Amsterdam , Noord-holland , Netherlands , Japan , Cambridge , Cambridgeshire , America , American , Suresh-senan

HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC

— Oral presentation at the European Lung Cancer Congress 2024 of Phase IIIb data demonstrating median PFS of 13.7 months and median OS not reached in treatment-naïve patients — — If...

Hong-kong , China , Poland , United-states , Shanghai , Polish , American , Ben-atwell , Zhou-yi , Atholl-tweedie , Astrazeneca , China-limited